123 related articles for article (PubMed ID: 15624040)
1. Fluvastatin reduces oxidative stress, decreases serum monocyte chemotactic protein-1 level and improves endothelial function in patients with hypercholesterolemia.
Leu HB; Wu CC; Wu TC; Lin SJ; Chen JW
J Formos Med Assoc; 2004 Dec; 103(12):914-20. PubMed ID: 15624040
[TBL] [Abstract][Full Text] [Related]
2. Effects of fluvastatin, an HMG-CoA reductase inhibitor, on serum levels of interleukin-18 and matrix metalloproteinase-9 in patients with hypercholesterolemia.
Leu HB; Chen JW; Wu TC; Ding YA; Lin SJ; Charng MJ
Clin Cardiol; 2005 Sep; 28(9):423-8. PubMed ID: 16250265
[TBL] [Abstract][Full Text] [Related]
3. Effect of fluvastatin on endothelium-dependent brachial artery vasodilation in patients after renal transplantation.
Hausberg M; Kosch M; Stam F; Heidenreich S; Kisters K; Rahn KH; Barenbrock M
Kidney Int; 2001 Apr; 59(4):1473-9. PubMed ID: 11260410
[TBL] [Abstract][Full Text] [Related]
4. Effects of statin treatment on endothelial function, oxidative stress and inflammation in patients with arterial hypertension and normal cholesterol levels.
Schneider MP; Schmidt BM; John S; Schmieder RE
J Hypertens; 2011 Sep; 29(9):1757-64. PubMed ID: 21799442
[TBL] [Abstract][Full Text] [Related]
5. Lipid-lowering therapy with fluvastatin inhibits oxidative modification of low density lipoprotein and improves vascular endothelial function in hypercholesterolemic patients.
Inoue T; Hayashi M; Takayanagi K; Morooka S
Atherosclerosis; 2002 Feb; 160(2):369-76. PubMed ID: 11849660
[TBL] [Abstract][Full Text] [Related]
6. Elderly patients with hypercholesterolaemia: a double-blind study of the efficacy, safety and tolerability of fluvastatin.
Lye M; Valacio R; Reckless JP; Ghosh AK; Findlay IN; Ghosh MK; Passmore AP; Fulcher RA
Coron Artery Dis; 1998; 9(9):583-90. PubMed ID: 9861520
[TBL] [Abstract][Full Text] [Related]
7. Effect of a 3-year therapy with the 3-hydroxy-3-methylglutaryl coenzyme a reductase-inhibitor fluvastatin on endothelial function and distensibility of large arteries in hypercholesterolemic renal transplant recipient.
Kosch M; Barenbrock M; Suwelack B; Schaefer RM; Rahn KH; Hausberg M
Am J Kidney Dis; 2003 May; 41(5):1088-96. PubMed ID: 12722044
[TBL] [Abstract][Full Text] [Related]
8. The differential effect of statins on oxidative stress and endothelial function: atorvastatin versus pravastatin.
Murrow JR; Sher S; Ali S; Uphoff I; Patel R; Porkert M; Le NA; Jones D; Quyyumi AA
J Clin Lipidol; 2012; 6(1):42-9. PubMed ID: 22264573
[TBL] [Abstract][Full Text] [Related]
9. Fluvastatin reduces soluble P-selectin and ICAM-1 levels in hypercholesterolemic patients: role of nitric oxide.
Romano M; Mezzetti A; Marulli C; Ciabattoni G; Febo F; Di Ienno S; Roccaforte S; Vigneri S; Nubile G; Milani M; Davì G
J Investig Med; 2000 May; 48(3):183-9. PubMed ID: 10822898
[TBL] [Abstract][Full Text] [Related]
10. Vasodilatory capacity of forearm resistance vessels is augmented in hypercholesterolemic patients after treatment with fluvastatin.
Schobel HP; Schmieder RE
Angiology; 1998 Sep; 49(9):743-8. PubMed ID: 9756426
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of once-daily vs twice-daily dosing with fluvastatin, a synthetic reductase inhibitor, in primary hypercholesterolemia.
Insull W; Black D; Dujovne C; Hosking JD; Hunninghake D; Keilson L; Knopp R; McKenney J; Stein E; Troendle AJ
Arch Intern Med; 1994 Nov; 154(21):2449-55. PubMed ID: 7979841
[TBL] [Abstract][Full Text] [Related]
12. Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients.
John S; Schneider MP; Delles C; Jacobi J; Schmieder RE
Am Heart J; 2005 Mar; 149(3):473. PubMed ID: 15864218
[TBL] [Abstract][Full Text] [Related]
13. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.
Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X
Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245
[TBL] [Abstract][Full Text] [Related]
14. Fluvastatin alters platelet aggregability in patients with hypercholesterolemia: possible improvement of intraplatelet redox imbalance via HMG-CoA reductase.
Haramaki N; Ikeda H; Takenaka K; Katoh A; Sugano R; Yamagishi S; Matsuoka H; Imaizumi T
Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1471-7. PubMed ID: 17379842
[TBL] [Abstract][Full Text] [Related]
15. [Effects of fluvastatin on plasma lipid abnormalities in hemodialysis patients with chronic renal failure].
Tanaka M; Itoh K; Matsushita K; Kitamura K; Nonoguchi H; Tomita K
Nihon Jinzo Gakkai Shi; 2002 May; 44(4):402-8. PubMed ID: 12073626
[TBL] [Abstract][Full Text] [Related]
16. Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery disease.
Eichstädt HW; Eskötter H; Hoffman I; Amthauer HW; Weidinger G
Am J Cardiol; 1995 Jul; 76(2):122A-125A. PubMed ID: 7604786
[TBL] [Abstract][Full Text] [Related]
17. Effect of dietary intervention and lipid-lowering treatment on brachial vasoreactivity in patients with ischemic heart disease and hypercholesterolemia.
Søndergaard E; Møller JE; Egstrup K
Am Heart J; 2003 May; 145(5):E19. PubMed ID: 12766751
[TBL] [Abstract][Full Text] [Related]
18. Effects of statins on vascular endothelial function in hypercholesterolemic patients with type 2 diabetes mellitus: fluvastatin vs. rosuvastatin.
Tomizawa A; Hattori Y; Suzuki K; Okayasu T; Kase H; Satoh H; Kasai K
Int J Cardiol; 2010 Sep; 144(1):108-9. PubMed ID: 19174316
[No Abstract] [Full Text] [Related]
19. Hypercholesterolaemia and treatment with statins do not alter L-arginine-induced changes of renal haemodynamics.
Fleischmann EH; Schlaich MP; Schmidt BM; Oehmer S; Schmieder RE
Nephrol Dial Transplant; 2002 Oct; 17(10):1758-65. PubMed ID: 12270981
[TBL] [Abstract][Full Text] [Related]
20. Different galenic formulations of fluvastatin have equal lipid-lowering potential but differ in reducing lipemia-induced endothelial dysfunction.
Westphal S; Abletshauser C; Luley C
Coron Artery Dis; 2009 Jan; 20(1):81-5. PubMed ID: 19060628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
